{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:27:37Z","timestamp":1791559657309,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019HM067"],"award-info":[{"award-number":["ZR2019HM067"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024LZL002"],"award-info":[{"award-number":["ZR2024LZL002"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019YQ30"],"award-info":[{"award-number":["ZR2019YQ30"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2019ZD24"],"award-info":[{"award-number":["ZR2019ZD24"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473485"],"award-info":[{"award-number":["82473485"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tstp20231252"],"award-info":[{"award-number":["tstp20231252"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["qnts20161035"],"award-info":[{"award-number":["qnts20161035"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008992","name":"Yantai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012620","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.colsurfb.2025.115180","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:43:35Z","timestamp":1759297415000},"page":"115180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Tumor exosome-based drug delivery system targeting ferroptosis and apoptosis for glioblastoma therapy"],"prefix":"10.1016","volume":"257","author":[{"given":"Yechang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.colsurfb.2025.115180_bib1","first-page":"1056","article-title":"Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma","volume":"24","author":"Gu","year":"2022","journal-title":"NeuroOncology"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115180_bib2","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115180_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","article-title":"Current and future strategies for treatment of glioma","volume":"40","author":"Bush","year":"2017","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.colsurfb.2025.115180_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120187","article-title":"Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery","volume":"255","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115180_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcancer.2017.12.011","article-title":"Targeting the warburg effect for cancer treatment: ketogenic diets for management of glioma","volume":"56","author":"Poff","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"23","key":"10.1016\/j.colsurfb.2025.115180_bib6","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma","volume":"318","author":"Stupp","year":"2017","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115180_bib7","first-page":"298","article-title":"Development of rodent glioblastoma models of mgmt-mediated temozolomide resistance","volume":"25","author":"Lee","year":"2023","journal-title":"NeuroOncology"},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115180_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.colsurfb.2025.115180_bib9","doi-asserted-by":"crossref","first-page":"11017","DOI":"10.1021\/acsnano.9b07789","article-title":"Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy","volume":"14","author":"Wan","year":"2020","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.colsurfb.2025.115180_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.colsurfb.2025.115180_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109084","article-title":"Luteolin, a flavonoid, as an anticancer agent: a review","volume":"116","author":"Imran","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.colsurfb.2025.115180_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.colsurfb.2025.115180_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127627","article-title":"The inhibition of \u03b2-catenin activity by luteolin isolated from paulownia flowers leads to growth arrest and apoptosis in cholangiocarcinoma","volume":"254","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115180_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210115","article-title":"Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases","volume":"1","author":"Zhang","year":"2021","journal-title":"Exploration"},{"key":"10.1016\/j.colsurfb.2025.115180_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116131","article-title":"A review on fucoidan antitumor strategies: from a biological active agent to a structural component of fucoidan-based systems","volume":"239","author":"Oliveira","year":"2020","journal-title":"Carbohyd. Polym."},{"issue":"345","key":"10.1016\/j.colsurfb.2025.115180_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7374","article-title":"P-selectin is a nanotherapeutic delivery target in the tumor microenvironment","volume":"8","author":"Shamay","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115180_bib17","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.3390\/md13042327","article-title":"Fucoidan and cancer: a multifunctional molecule with anti-tumor potential","volume":"13","author":"Atashrazm","year":"2015","journal-title":"Mar. Drugs"},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115180_bib18","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/j.apsb.2022.08.013","article-title":"Smart drug delivery systems for precise cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"issue":"7","key":"10.1016\/j.colsurfb.2025.115180_bib19","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1007\/s12274-023-5568-3","article-title":"LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"Nano Res."},{"issue":"17","key":"10.1016\/j.colsurfb.2025.115180_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105451","article-title":"Synchronous disintegration of ferroptosis defense axis via engineered exosome-conjugated magnetic nanoparticles for glioblastoma therapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"issue":"6478","key":"10.1016\/j.colsurfb.2025.115180_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.colsurfb.2025.115180_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","article-title":"Using exosomes, naturally-equipped nanocarriers, for drug delivery","volume":"219","author":"Batrakova","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.colsurfb.2025.115180_bib23","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","article-title":"Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy","volume":"10","author":"Yong","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115180_bib24","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.colsurfb.2025.115180_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15287","article-title":"Exosomes maintain cellular homeostasis by excreting harmful DNA from cells","volume":"8","author":"Takahashi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2025.115180_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.colsurfb.2025.115180_bib27","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1158\/1078-0432.CCR-21-0833","article-title":"Antitumor activity of a mitochondrial-targeted HSP90 inhibitor in gliomas","volume":"28","author":"Wei","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2025.115180_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113605","article-title":"Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma","volume":"381","author":"Song","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.115180_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2020.12.015","article-title":"Epigenetics of glioblastoma multiforme: from molecular mechanisms to therapeutic approaches","volume":"83","author":"Uddin","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.colsurfb.2025.115180_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin. J. Oncol. Nurs."},{"issue":"11","key":"10.1016\/j.colsurfb.2025.115180_bib31","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients","volume":"10","author":"Ostermann","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.colsurfb.2025.115180_bib32","first-page":"1300","article-title":"Temozolomide-associated hypermutation in gliomas","volume":"20","author":"Choi","year":"2018","journal-title":"NeuroOncology"},{"key":"10.1016\/j.colsurfb.2025.115180_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101448","article-title":"Anti-alcoholism drug disulfiram for targeting glioma energy metabolism using BBB-penetrating delivery of fixed-dose combination","volume":"44","author":"Zhao","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.colsurfb.2025.115180_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jconrel.2024.01.004","article-title":"NIR-promoted ferrous ion regeneration enhances ferroptosis for glioblastoma treatment","volume":"368","author":"Xue","year":"2024","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115180_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","article-title":"Autophagy-dependent ferroptosis: machinery and regulation","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.colsurfb.2025.115180_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122795","article-title":"Responsive and traceless assembly of iron nanoparticles and 131I labeled radiopharmaceuticals for ferroptosis enhanced radio-immunotherapy","volume":"313","author":"Shen","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2025.115180_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.freeradbiomed.2023.09.014","article-title":"Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression","volume":"208","author":"Zheng","year":"2023","journal-title":"Free Radic. Bio. Med."},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115180_bib38","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3390\/ijms24043632","article-title":"The formation of morphologically stable lipid nanocarriers for glioma therapy","volume":"24","author":"Pavlov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2025.115180_bib39","article-title":"Cell-derived biomimetic drug delivery system for inflammatory bowel disease therapy","volume":"29","author":"Yang","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"615","key":"10.1016\/j.colsurfb.2025.115180_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb6981","article-title":"Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.colsurfb.2025.115180_bib41","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jconrel.2020.10.020","article-title":"Challenges in the development and establishment of exosome-based drug delivery systems","volume":"329","author":"Wang","year":"2021","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.colsurfb.2025.115180_bib42","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-targeted codelivery of Bcl-2\/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115180_bib43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.nanolett.0c04753","article-title":"A biomimetic drug delivery system by integrating grapefruit extracellular vesicles and doxorubicin-loaded heparin-based nanoparticles for glioma therapy","volume":"21","author":"Niu","year":"2021","journal-title":"Nano Lett."},{"issue":"50","key":"10.1016\/j.colsurfb.2025.115180_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson\u2019s disease","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.colsurfb.2025.115180_bib45","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.apsb.2021.08.013","article-title":"Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas","volume":"12","author":"Cui","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.colsurfb.2025.115180_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2025.05.393","article-title":"Lipid peroxidation, ferroptosis, and antioxidants","volume":"237","author":"Noguchi","year":"2025","journal-title":"Free Radic. Bio Med."},{"issue":"8","key":"10.1016\/j.colsurfb.2025.115180_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525006873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525006873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:16:39Z","timestamp":1773152199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525006873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0927776525006873"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115180","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor exosome-based drug delivery system targeting ferroptosis and apoptosis for glioblastoma therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115180"}}